(Q51561515)

English

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

scientific article published in August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

author name string

V De Mitrio

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

G De Pergola

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

R Marino

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

M Sciaraffia

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

C Pagano

6

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

F A Scaraggi

7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

L Di Lorenzo

8

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

R Giorgino

9

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

publication date

1 August 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

48

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

8

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

960-964

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

Body weight and risk of myocardial infarction and death in the adult population of eastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Central obesity and coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Regional adiposity and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Insulin resistance and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Influence of free testosterone on antigen levels of plasminogen activator inhibitor-1 in premonopausal women with central obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Overexpression of the obese (ob) gene in adipose tissue of human obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin response

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Identification of the human leptin 5'-flanking sequences involved in the trophoblast-specific transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

The stomach is a source of leptin

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Hypertriglyceridemia and regulation of fibrinolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Sympathetic and cardiorenal actions of leptin.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990190-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0026-0495(99)90190-7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10459558

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51561515&oldid=1517927302"